tiprankstipranks
Trending News
More News >
IRLAB Therapeutics AB Class A (DE:6IRA)
FRANKFURT:6IRA

IRLAB Therapeutics AB Class A (6IRA) Revenue

Compare
1 Followers

IRLAB Therapeutics AB Class A Revenue

IRLAB Therapeutics AB Class A had a revenue of 14.72M in the quarter ending Dec 31, 2025, with -21.87%. This bring the company's revenue in the last twelve months to 57.46M, Increased -32.84%. In the fiscal year ending Dec 31, 2025, IRLAB Therapeutics AB Class A had annual revenue of 57.46M with -39.28% growth.
Revenue (ttm)
57.46M
Revenue Growth
P/S Ratio
0.22
Revenue/Employee
€1,853,613
Employees
31
Market Cap
€12.53M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
57.46M-37.17M-39.28%
Dec 31, 2024
94.63M88.95M+1,566.57%
Dec 31, 2023
5.68M-55.46M-90.71%
Dec 31, 2022
61.14M-146.65M-70.58%
Dec 31, 2021
207.78M207.48M+69,160.67%
Dec 31, 2020
300.00K274.00K+1,053.85%
Dec 31, 2019
26.00K8.00K+44.44%
Dec 31, 2018
18.00K-91.00K-83.49%
Dec 31, 2017
109.00K